- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06065332
Post-Procedural Biotech Cellulose Mask
Randomized Split-Face Study Using a Post-Procedural Biotech Cellulose Mask to Improve Patient Comfort & Downtime
Background: There are many post-procedural treatments touted to improve comfort and decrease downtime, but very few prospective randomized studies.
Aims: To analyze the safety and efficacy of a post-procedural biotech cellulose mask Patients/Method: Fifteen patients undergoing either a microneedling with radiofrequency (n=5), non-ablative fractional (n=5), or full erbium;YAG resurfacing (n=5) treatment were randomized to receive a Velez biotech cellulose mask on one side of the face for 30 minutes after the procedure and for two hours a day until healed. Canfield Visia photos and thermal photographs were taken 30 minutes after the procedure and daily until healed. The investigator and blind evaluators reviewed the photos and subjects answered daily questionnaires.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A dual center study was performed at a private practice in Boynton Beach and Boca Raton Florida. The study was carried out in accordance with the ethical guidelines and principles of the 1975 Declaration of Helsinki and good clinical practice. The protocol was approved on May 12th, 2022, by Sterling IRB.
Study Design:
The clinical research coordinator and investigator recruited, enrolled, and assigned 15 subjects into 3 arms, each with 5 subjects over two months. The side assigned a biotech cellulose mask for each subject was determined by random sorting using a computer-generated sequence and written on a label adhered to the mask packaging so the patient could remember while at home.
Treatment:
Topical anesthetic cream (benzocaine 20%, lidocaine 10%, and tetracaine 6%) was applied to the face for 30 minutes and wiped off with 70% isopropyl alcohol in all three arms. Those in arm 1 received a non-ablative fractionated thulium treatment (Moxi; Sciton) those in arm 2 received a microneedling with radiofrequency treatment (Secret; Cutera), and those in arm 3 received a fully ablative erbium yttrium aluminum garnet (Er:YAG) laser resurfacing (Contour TRL; Sciton). Immediately after the procedure a biotech cellulose mask was applied (Hydration mask; Velez by Vesna) and left on for thirty minutes. Then digital photography using Canfield's imaging system and Flir's thermal camera was done. In addition, a subject questionnaire on satisfaction, erythema, edema, and pain levels after the procedure was completed. Patients used the typical post-care treatment on both sides of their face such as Vaseline for laser resurfacing and a hydrating serum for the NAFR and MRF. They were given additional half-sided masks to apply to the same assigned side of their face at home for at least two hours each day for the duration of the study. They returned to the office daily for questionnaires and photographs until deemed fully healed by the primary investigator signifying the end of the study. At all follow up visits, the primary investigator assessed the subject for any side effects and subjects were asked about side effects in questionnaires.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Boynton Beach, Florida, United States, 33472
- Siperstein Dermatology Group
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients willing to undergo a cosmetic procedure
- Patients willing to apply a mask for 30 minutes after the procedure and daily
- Patients willing to return to the office to take photos daily and allow use of photos in publication
Exclusion Criteria:
- History of auto-immune conditions
- History of keloids
- History of severe anaphylactic reactions
- Patients taking either anti-coagulants, chemotherapy, immunosuppressive agents, immunomodulatory agents, diuretics, antihistamines, or anti-inflammatory two weeks before or during planned treatments
- Patients who are pregnant or nursing.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Velez Intense Hydration Mask® (biotech cellulose face mask) Right Side
For 30 minutes after an aesthetic procedure, a Velez Intense Hydration Mask® (biotech cellulose face mask) was applied to the right side of the face
|
Application to one randomized side half of a Velez Intense Hydration Mask® (biotech cellulose face mask)
|
Experimental: Velez Intense Hydration Mask® (biotech cellulose face mask) Left Side
For 30 minutes after an aesthetic procedure, a Velez Intense Hydration Mask® (biotech cellulose face mask) was applied to the left side of the face
|
Application to one randomized side half of a Velez Intense Hydration Mask® (biotech cellulose face mask)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Temperature
Time Frame: 30 minutes after the procedure
|
Change in skin temperature
|
30 minutes after the procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Robyn D Siperstein, MD, Siperstein Dermatology Group
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Velez
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Temperature Change, Body
-
University of WinchesterPhysiolab Technologies LtdCompletedTemperature Change, BodyUnited Kingdom
-
G Medical Innovations Ltd.Unknown
-
University of Medicine and Pharmacy at Ho Chi Minh...RecruitingTemperature Change, BodyVietnam
-
University of Missouri-ColumbiaTerminatedTemperature Change, BodyUnited States
-
Infrared Cameras IncorporateCompleted
-
St. John's Research InstituteIndian Institute of ScienceCompletedTemperature Change, BodyIndia
-
Hacettepe UniversityCompletedTemperature Change, BodyTurkey
-
University of WinchesterPhysiolab Technologies LtdNot yet recruiting
-
Drägerwerk AG & Co. KGaATerminatedTemperature Change, BodyGermany
-
Fundación Instituto de Estudios de Ciencias de...Instituto de Investigación Biomédica de SalamancaCompletedTemperature Change, BodySpain
Clinical Trials on Velez Intense Hydration Mask® (biotech cellulose face mask)
-
AlyatecMedicomCompletedAllergic Rhinitis | Allergic AsthmaFrance
-
University of BirminghamBirmingham Community Healthcare NHSCompleted
-
Geneve TEAM AmbulancesService de protection et sauvetage Lausanne (SPSL), Emergency Medical Services... and other collaboratorsCompletedCardiac Arrest | Emergency Medical Services | Resuscitation | Cardiopulmonary ArrestSwitzerland
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil